Rocket Pharmaceuticals Files 8-K
Ticker: RCKTW · Form: 8-K · Filed: Jul 24, 2025 · CIK: 1281895
| Field | Detail |
|---|---|
| Company | Rocket Pharmaceuticals, Inc. (RCKTW) |
| Form Type | 8-K |
| Filed Date | Jul 24, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: sec-filing, 8-k
TL;DR
Rocket Pharma filed an 8-K on 7/24/25, mostly procedural stuff.
AI Summary
On July 24, 2025, Rocket Pharmaceuticals, Inc. filed an 8-K report. The filing primarily concerns "Other Events" and "Financial Statements and Exhibits." No specific material events or financial details beyond the filing itself were disclosed in the provided text.
Why It Matters
This filing indicates Rocket Pharmaceuticals is providing updates or submitting required documentation to the SEC, which is standard for public companies.
Risk Assessment
Risk Level: low — The filing is a routine 8-K with no disclosed material events, indicating no immediate new risks.
Key Players & Entities
- ROCKET PHARMACEUTICALS, INC. (company) — Registrant
- INOTEK PHARMACEUTICALS CORP (company) — Former company name
- July 24, 2025 (date) — Date of report
FAQ
What is the primary purpose of this 8-K filing for Rocket Pharmaceuticals, Inc.?
The filing is primarily for "Other Events" and "Financial Statements and Exhibits," indicating routine updates or submissions to the SEC.
When was this 8-K report filed?
The report was filed on July 24, 2025.
What is the principal executive office address for Rocket Pharmaceuticals, Inc.?
The address is 9 Cedarbrook Drive, Cranbury, NJ 08512.
What was Rocket Pharmaceuticals, Inc.'s former company name?
The former company name was INOTEK PHARMACEUTICALS CORP.
What is the SEC file number for Rocket Pharmaceuticals, Inc.?
The SEC file number is 001-36829.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on July 24, 2025 regarding ROCKET PHARMACEUTICALS, INC. (RCKTW).